<ul><li>DexCom launches its proprietary GenAI platform, integrating advanced AI into glucose biosensing technology.</li><li>The platform leverages Google Cloud's Vertex AI and Gemini models to analyze individual health data and provide personalized insights for users.</li><li>The first product to use GenAI technology is Stelo, an over-the-counter glucose biosensor FDA-cleared in the US.</li><li>Dexcom plans to introduce additional GenAI-powered features in the future to help users make informed lifestyle decisions.</li></ul>

DexCom Launches GenAI Platform for Glucose Biosensing, Leveraging Google Cloud

Discover more